GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Down 58.6% in April

GlobeStar Therapeutics Co. (OTCMKTS:GSTCGet Rating) was the target of a large drop in short interest during the month of April. As of April 30th, there was short interest totalling 7,500 shares, a drop of 58.6% from the April 15th total of 18,100 shares. Based on an average daily volume of 8,682,900 shares, the short-interest ratio is currently 0.0 days.

GSTC stock remained flat at $$0.00 during midday trading on Friday. The company’s stock had a trading volume of 8,278,142 shares, compared to its average volume of 4,384,730. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01. GlobeStar Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.08.

GlobeStar Therapeutics Company Profile (Get Rating)

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.

Featured Stories

Receive News & Ratings for GlobeStar Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobeStar Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.